Neonatal encephalopathy (NE) is a broad term for disrupted brain function in newborns during the first days of life. It affects an estimated 3 to 8.5 out of every 1,000 live births worldwide, with more than 1.2 million newborns affected each year. The condition ranges from mild, where a baby may seem jittery and overly alert, to severe, where the infant is unresponsive and limp. Outcomes depend heavily on the cause, the severity, and how quickly treatment begins.
What Causes Neonatal Encephalopathy
For years, oxygen deprivation during birth was treated as the default explanation for NE. While a lack of oxygen and blood flow to the brain (called hypoxic-ischemic encephalopathy, or HIE) is one of the most common causes, it is far from the only one. The condition can result from infections picked up before or during birth, abnormalities in the placenta, blood clotting disorders, neonatal stroke, metabolic disorders, and genetic factors. Often, multiple causes overlap. A baby might have an underlying genetic vulnerability that makes them more susceptible to injury from a difficult delivery, for example.
Identifying the actual cause matters because it shapes treatment. A baby whose encephalopathy stems from an inherited metabolic disorder needs a very different approach than one whose brain was injured by oxygen deprivation. Brain imaging can sometimes point toward the cause: patterns like a focal stroke, isolated bleeding, or unusual metabolic signatures on MRI suggest something other than oxygen deprivation was responsible.
How Brain Injury Unfolds in Two Phases
When oxygen deprivation is the cause, brain injury doesn’t happen all at once. It unfolds in two distinct waves, and understanding this timeline is central to why treatment is time-sensitive.
During the first phase, the brain’s energy supply drops sharply. The brain normally runs on a constant supply of oxygen and glucose. When that supply is cut off, cells burn through their glucose reserves quickly, and waste products like lactic acid build up. This initial energy crisis damages vulnerable brain cells, particularly those involved in signaling between neurons.
After resuscitation, there’s a brief window where energy levels in the brain partially recover. But starting around 6 hours after the initial injury, a second, delayed wave of energy failure kicks in. During this phase, the damage deepens. Cellular energy reserves are exhausted again, inflammation ramps up, calcium floods into cells in toxic amounts, and highly reactive molecules called free radicals cause further destruction. This secondary phase is the main target of current treatment, because it represents a window where intervention can still limit the extent of permanent injury.
Mild, Moderate, and Severe Stages
Doctors classify NE into three stages based on how the baby looks and responds neurologically. This staging system, originally developed in the 1970s, remains the foundation for deciding which babies need treatment and for predicting outcomes.
- Stage 1 (mild): The baby appears hyper-alert with exaggerated reflexes and may seem irritable or jittery. Brain wave activity is typically normal. These infants generally recover without intervention.
- Stage 2 (moderate): The baby is lethargic with reduced muscle tone, may adopt a characteristic flexed posture, and often has seizures. This is the group where cooling therapy has the strongest evidence of benefit.
- Stage 3 (severe): The baby is deeply unresponsive, completely limp, and may have absent brainstem reflexes. Brain wave patterns are severely disrupted or nearly flat. Outcomes in this group are often poor even with treatment.
How Doctors Assess the Injury
Beyond the physical exam, two key tools help doctors evaluate how serious the injury is and what to expect going forward.
A simplified form of brain wave monitoring, called amplitude-integrated EEG, is often placed on the baby’s head shortly after birth. The patterns it records are strongly linked to outcomes. A normal background pattern with recognizable sleep-wake cycles is a reassuring sign. Severely abnormal patterns, such as very low electrical activity, a flat tracing, or continuous seizure activity, are associated with a much higher likelihood of death, cerebral palsy, or epilepsy. In one study of infants with severely abnormal readings, nearly 73% of those with poor neurological outcomes had both very low brain wave amplitude and no detectable sleep-wake cycling.
MRI of the brain, typically performed several days after birth, provides the most detailed picture of where and how extensively the brain was injured. The specific pattern of injury visible on MRI can help distinguish oxygen deprivation from other causes like stroke, bleeding, or metabolic disease.
Cooling Therapy: The Primary Treatment
Therapeutic hypothermia, commonly called cooling therapy, is the standard treatment for babies with moderate to severe encephalopathy caused by oxygen deprivation. The baby’s core body temperature is lowered to 33.5°C (about 92.3°F) and held there for 72 hours. The goal is to slow down the destructive processes of the secondary energy failure phase before they cause permanent damage.
Timing is critical. The treatment must begin within 6 hours of birth to be most effective, which is why identifying encephalopathy quickly is so important. Babies who present between 6 and 24 hours after birth may still be considered for cooling, but the expected benefit is smaller and the decision involves weighing potential risks with the family.
Multiple large trials have tested cooling therapy, and the results consistently show meaningful benefit. In the largest and most recent of these, the Infant Cooling Evaluation trial, death or significant disability at age 2 occurred in 51% of cooled babies compared with 66% of those who received standard care alone. An earlier trial by the National Institutes of Health found that cooling reduced the combined risk of death or disability by 28%. These numbers make clear that cooling helps, but they also show that it doesn’t prevent all injury. Roughly half of treated babies with moderate or severe encephalopathy still face significant challenges.
Long-Term Outcomes for Survivors
The range of outcomes after neonatal encephalopathy is wide. Some children recover fully, while others face lifelong disabilities including cerebral palsy, epilepsy, intellectual disability, and hearing or vision problems. Severity at birth is the strongest predictor: babies with stage 1 encephalopathy almost universally do well, those with stage 3 face the highest risk of severe disability or death, and stage 2 falls in between.
Even children who appear to recover well in infancy can show subtler difficulties as they grow. Research following children with mild and moderate encephalopathy into school age has found significantly lower scores on tests of attention, executive functioning, verbal reasoning, and fine motor skills compared to healthy peers. These children were also more likely to need extra support at school, and their parents reported more difficulties with peer relationships and social competence. These findings are important because they mean that a “normal” neurological exam in infancy doesn’t guarantee smooth sailing later. Children who had NE, even mild cases, benefit from developmental follow-up through their school years.
Why NE Remains a Global Health Problem
The burden of neonatal encephalopathy falls disproportionately on lower-income countries, where the incidence is 8 to 16 times higher than in wealthy nations. This gap reflects differences in access to prenatal care, skilled birth attendants, fetal monitoring, and neonatal intensive care. Cooling therapy requires specialized equipment, continuous monitoring, and trained staff, resources that are not widely available in the settings where NE is most common. Even in high-income countries, outcomes depend on rapid recognition and transfer to a center equipped for cooling, which means geography and timing still play an outsized role in whether a baby receives optimal care.